Security of neurohormonal blocking with sacubitril / valsartan, iSGLT2 and mineralocorticoid receptor antagonist in patients with heart failure with reduced eyection fraction and diabetes mellitus

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Pharmacology and Pharmacotherapy Cardiovascular Pharmacotherapy HFA Premium Access Heart Failure 2019

ESC 365 is supported by

ESC 365 is supported by